Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration.
WORCESTER, MA, December 16, 2008 (GlobeNewswire) – Generex Biotechnology Corporation (NasdaqCM:GNBT, www.generex.com) and Pevion Biotech Ltd. (www.pevion.com) have signed an agreement to work together to develop next-generation vaccines and immunotherapeutic products.
Destum Partners Secures Partnership For Its Client Medisyn Technologies With Kraft Foods
Medisyn Technologies Collaborates With Kraft Foods to Drive Discovery of Effective Bioactive Ingredients Suitable for Food Use.
MINNEAPOLIS, MN, January 14, 2009 – “Medisyn Technologies, Inc., announced today a research and licensing collaboration with Kraft Foods Global Inc. to discover effective bioactive ingredients suitable for food use. The work, which began in December, 2008, utilizes Medisyn’s Forward Engineering technology platform to identify, analyze and optimize promising bioactive compounds. This technology accurately predicts how a compound will behave based on its structure, greatly streamlining the discovery and development process of food ingredients that can be used to provide healthier choices for consumers.”
KOL Contact Released
CHARLOTTE, N.C., May 23 /PRNewswire/ – Destum Partners is pleased to announce the launch of their first market analytics product focused on the acquisition of data through primary market research. Destum Partners developed an extensive network of Key Opinion Leaders that have now been captured in KOL CONTACT. KOL CONTACT is a robust database that contains detailed information about thought leaders from a variety of disciplines and covering a variety of therapeutics areas. The first product available under the KOL CONTACT brand exclusively focuses on Oncology in the U.S.